📣 VC round data is live. Check it out!

Shin Young Securities Valuation Multiples

Discover revenue and EBITDA valuation multiples for Shin Young Securities and similar public comparables like Kyobo Securities, Arendals Fossekompani, Vivenio Residencial, Oaktree Specialty Lending and more.

Shin Young Securities Overview

About Shin Young Securities

Shin Young Securities Co Ltd is a Japanese company which is engaged in providing financial products and services. It mainly offers broking trading service on securities such as stocks, bonds, futures, options; research service on domestic and overseas financial market; wealth management services; investment banking including underwriting corporate bonds, structured financing, real estate financing; and issuance of equity-linked securities, derivative-linked securities and other. The company divides its business in four business fields as Brokerage business, Wealth Management business, Investment Banking business and Capital Market business.


Founded

1956

HQ

South Korea

Employees

N/A

Financials (FY)

Revenue: $239M
Net Income: $74M

EV

$2B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Shin Young Securities Financials

Shin Young Securities reported last fiscal year revenue of $239M.

In the same fiscal year, Shin Young Securities generated $74M in net income.


Shin Young Securities P&L

In the most recent fiscal year, Shin Young Securities reported revenue of $239M and net income of $74M.

Shin Young Securities is profitable as of last fiscal year, with net margin of 31%.

See analyst estimates for Shin Young Securities
Last FY202320242025202620272028
Revenue$239M$242M$243M$239M
Net Profit$74M$89M$80M$74M
Net Margin31%37%33%31%

Financial data powered by Morningstar, Inc.

Shin Young Securities Stock Performance

Shin Young Securities has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


Shin Young Securities' stock price is $140.31.

Shin Young Securities share price increased by 5.9% in the last 30 days, and by 86.4% in the last year.

Shin Young Securities has an EPS (earnings per share) of $9.21.

See more trading valuation data for Shin Young Securities
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B4.8%5.9%-8.3%86.4%$9.21

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Shin Young Securities Valuation Multiples

Shin Young Securities trades at 8.5x EV/Revenue multiple.

See NTM and 2027E valuation multiples for Shin Young Securities

Shin Young Securities Financial Valuation Multiples

As of May 5, 2026, Shin Young Securities has market cap of $1B and EV of $2B.

Shin Young Securities has a P/E ratio of 15.2x.

Last FY202320242025202620272028
EV/Revenue8.5x8.5x8.4x8.5x
P/E15.2x12.6x14.1x15.2x
EV/FCF(6.6x)(8.0x)(5.9x)(6.6x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Shin Young Securities Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Shin Young Securities Margins & Growth Rates

In the most recent fiscal year, Shin Young Securities reported net margin of 31%.

See estimated margins and future growth rates for Shin Young Securities

Shin Young Securities Margins

Last FY20242025202720282029
Net Margin31%33%31%
FCF Margin(129%)(142%)(129%)

Shin Young Securities Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth1%(2%)
Net Profit Growth(11%)(7%)
FCF Growth35%(11%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Shin Young Securities Operational KPIs

Access forward-looking KPIs for Shin Young Securities
Last FY202320242025202620272028
S&M Expenses to Revenue5%4%5%5%
G&A Expenses to Revenue9%7%8%9%
Opex to Revenue58%53%56%58%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Shin Young Securities Competitors

Shin Young Securities competitors include Kyobo Securities, Arendals Fossekompani, Vivenio Residencial, Oaktree Specialty Lending, abrdn Healthcare Invts, Vietcap, Berliner, Tokai Tokyo Financial Holdings, P10 and Burford Capital.

Most Shin Young Securities public comparables operate across Investment Banking, Investment Brokerage and Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Kyobo Securities(0.6x)(0.7x)
Arendals Fossekompani2.9x42.2x28.6x101.4x
Vivenio Residencial22.4x13.1x
Oaktree Specialty Lending110.1x9.0x8.8x
abrdn Healthcare Invts11.4x
Vietcap6.0x5.8x12.4x
Berliner4.4x16.6x
Tokai Tokyo Financial Holdings5.3x4.9x29.2x

This data is available for Pro users. Sign up to see all Shin Young Securities competitors and their valuation data.

Start Free Trial

Shin Young Securities Investment Activity

Shin Young Securities has invested in 13 companies to date.

Latest investment by Shin Young Securities was on February 23rd 2026. Shin Young Securities invested in BOS Semiconductors in their $61M Series A round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Shin Young Securities

BOS Semiconductors
ProtoPie
Ubix Therapeutics
AIRS Medical
Description
BOS Semiconductors is a developer of power management and signal processing chips tailored for electric vehicles and advanced driver assistance systems. Based in Germany with production facilities in Asia, it supplies automotive OEMs such as Volkswagen and BMW with integrated circuits for battery management and infotainment systems.
ProtoPie is a Seoul-headquartered no-code tool for prototyping mobile interactions launched in 2016. Adopted by clients including Google, Microsoft, R/GA, and IDEO, it enables designers to harness native device sensors, gestures, and animations without coding, supporting complex prototypes for iOS and Android.
Ubix Therapeutics is a Shanghai-based biopharma company advancing small-molecule inhibitors for solid tumors like lung and breast cancer. Lead drug UBX-1325 targets KRAS mutations in Phase I trials. The firm uses structure-based design for PROTACs degrading oncoproteins. Established in 2018, Ubix partners with CROs in China for preclinical screening.
AIRS Medical is a healthcare startup offering AI-based diagnostic tests and robotics to enhance patient experiences and operational efficiency. Seoul-based, the company developed SwiftMR, an AI-powered MRI reconstruction platform that improves image quality from low-field scans. AIRS Medical's solutions reduce scan times and artifacts, deployed in hospitals across Asia.
HQ CountrySouth KoreaSouth KoreaSouth KoreaSouth Korea
HQ City
Seongnam
Seoul
Seoul
Seoul
Deal Date23 Feb 202622 Jan 202523 Dec 202410 Jul 2024
RoundSeries ASeries BSeries CSeries C
Raised$61M$21M$18M$20M
InvestorsBSK Investment; E&Venture Partners; HB Investment; Industrial Bank of Korea; K and Investment Partners; KB Investment; Korea Development Bank; Partners Investment; PI Partners; Shin Young Securities; UAMCO; Woori Venture PartnersAxis Investment; BSK Investment; CJ Investment; HB Investment; Industrial Bank of Korea; Korea Development Bank; LB Investment; Shin Young SecuritiesAtinum Investment; Industrial Bank of Korea; Korea Development Bank; Korea Technology Finance Corporation; Mint Venture Partners; Quad Asset Management; Shin Young Securities; Solidus Investment; TONY Investment; Union Investment PartnersBSK Investment; Dunamu & Partners; GS Ventures; Hana Ventures; Klim Ventures; Premier Partners; SGI Venture Capital; Shin Young Securities
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Shin Young Securities investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Shin Young Securities

When was Shin Young Securities founded?Shin Young Securities was founded in 1956.
Where is Shin Young Securities headquartered?Shin Young Securities is headquartered in South Korea.
Who is the CEO of Shin Young Securities?Shin Young Securities' CEO is Jong-Seok Won.
Is Shin Young Securities publicly listed?Yes, Shin Young Securities is a public company listed on Korea Exchange.
What is the stock symbol of Shin Young Securities?Shin Young Securities trades under 001720 ticker.
When did Shin Young Securities go public?Shin Young Securities went public in 1987.
Who are competitors of Shin Young Securities?Shin Young Securities main competitors include Kyobo Securities, Arendals Fossekompani, Vivenio Residencial, Oaktree Specialty Lending, abrdn Healthcare Invts, Vietcap, Berliner, Tokai Tokyo Financial Holdings, P10, Burford Capital.
What is the current market cap of Shin Young Securities?Shin Young Securities' current market cap is $1B.
What is the current revenue of Shin Young Securities?Shin Young Securities' last fiscal year revenue is $239M.
What is the current EV/Revenue multiple of Shin Young Securities?Current revenue multiple of Shin Young Securities is 8.5x.
Is Shin Young Securities profitable?No, Shin Young Securities is not profitable.
How many companies Shin Young Securities has acquired to date?Shin Young Securities hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Shin Young Securities has invested to date?As of May 2026, Shin Young Securities has invested in 13 companies.
What was the last Shin Young Securities investment?On 23rd February 2026 Shin Young Securities invested in BOS Semiconductors, participating in a $61M Series A round, alongside BSK Investment, E&Venture Partners, HB Investment, Industrial Bank of Korea, K and Investment Partners, KB Investment, Korea Development Bank, Partners Investment, PI Partners, UAMCO, and 1 other investor.
In what companies Shin Young Securities invested in?Shin Young Securities invested in BOS Semiconductors, CUBOX, K-Auction Co, ProtoPie, AITRICS, Wonderwall, AIRS Medical, AEOL, Ubix Therapeutics, Rodwin, Sangwha, MAYMUST, and Twee.

See public comps similar to Shin Young Securities

Lists including Shin Young Securities

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial